The AKAP1 gene plays a critical role in the proper functioning of mitochondria, the energy-producing organelles within our cells. Mutations in the AKAP1 gene can lead to a range of mitochondrial disorders, which can manifest in various ways depending on the tissues affected. These disorders can have profound effects on health, potentially impacting the nervous system, muscles, heart, and other vital organs.
To diagnose conditions related to the AKAP1 gene, genetic testing can be invaluable. In the UAE, DNA Labs offers a specialized test designed to identify mutations in the AKAP1 gene. This test is crucial for individuals suspected of having mitochondrial disorders linked to the AKAP1 gene, as it can confirm the diagnosis and help in the management of the condition.
The cost of the AKAP1-related genetic test at DNA Labs UAE is 4400 AED. This investment covers the detailed analysis required to detect any mutations in the AKAP1 gene. By opting for this test, patients and their families can gain essential insights into their genetic makeup, which can inform treatment strategies and provide a clearer understanding of the prognosis for mitochondrial disorders associated with AKAP1 mutations.
The DGUOK Gene Mitochondrial DNA Depletion Syndrome Genetic Test is a specialized diagnostic tool used to identify mutations in the DGUOK gene, which are linked to mitochondrial DNA depletion syndrome (MDDS). MDDS is a group of autosomal recessive disorders characterized by a significant reduction in mitochondrial DNA in affected tissues, leading to a wide range of clinical manifestations including liver failure, neurological abnormalities, and muscle weakness. The test is essential for confirming the diagnosis, understanding the disease's progression, and making informed decisions regarding management and treatment.
Performed at DNA Labs UAE, this genetic test involves analyzing the patient's DNA to detect mutations in the DGUOK gene. The process is meticulous and requires advanced laboratory techniques to ensure accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed.
By opting for this test at DNA Labs UAE, patients and their families gain crucial insights into the genetic underpinnings of mitochondrial DNA depletion syndrome, facilitating targeted interventions and enabling a better quality of life for affected individuals.
The SUCLA2 Gene Mitochondrial DNA Depletion Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the SUCLA2 gene. This gene plays a critical role in mitochondrial function and energy production within cells. Mutations in the SUCLA2 gene can lead to mitochondrial DNA depletion syndrome (MDS), a severe and often fatal condition characterized by a significant reduction in mitochondrial DNA within cells. This condition manifests with a wide range of symptoms, including muscle weakness, neurodevelopmental delays, and metabolic disturbances.
The test is particularly important for individuals showing symptoms suggestive of MDS or those with a family history of the condition, as early diagnosis can significantly impact management and treatment strategies. The process involves collecting a DNA sample, usually through a blood draw, which is then analyzed in the laboratory to detect any mutations in the SUCLA2 gene.
The cost of the SUCLA2 Gene Mitochondrial DNA Depletion Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis necessary to provide accurate and reliable results, aiding in the diagnosis of this complex condition. Given the specialized nature of this test and its potential to influence patient care, it represents a crucial step in the diagnostic process for affected individuals and their families.
The TK2 Gene Mitochondrial DNA Depletion Syndrome Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the TK2 gene, which are associated with mitochondrial DNA depletion syndrome (MDS). This condition is a rare, autosomal recessive disorder that leads to a significant reduction in mitochondrial DNA in affected tissues, primarily impacting muscular and neurological functions. Symptoms can vary but often include muscle weakness, motor delays, and respiratory issues.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw, and analyzing it for specific genetic mutations in the TK2 gene. The results can provide crucial information for the diagnosis, management, and treatment planning of the syndrome, allowing for a more targeted approach to care. DNA Labs UAE utilizes advanced genetic sequencing technologies to ensure accurate and reliable testing outcomes, supporting patients and healthcare providers in navigating the complexities of mitochondrial DNA depletion syndrome.
The MGME1 gene mitochondrial DNA depletion syndrome type 11 (MTDPS11) genetic test is a specialized diagnostic tool used to identify mutations in the MGME1 gene, which can lead to mitochondrial DNA depletion syndrome type 11. This condition is a rare autosomal recessive disorder characterized by a significant reduction in mitochondrial DNA within cells, leading to a variety of symptoms including muscle weakness, neurological problems, and other systemic issues.
The test is performed by extracting DNA from a patient's blood sample and analyzing it for specific mutations in the MGME1 gene that are known to cause the syndrome. This precise genetic testing is crucial for the accurate diagnosis of MTDPS11, enabling healthcare providers to tailor treatment plans to the specific needs of the patient, and also offers valuable information for family planning.
The cost of the MGME1 gene mitochondrial DNA depletion syndrome type 11 genetic test is 4400 AED. This test is available at DNA Labs UAE, a leading laboratory known for its advanced genetic testing services. DNA Labs UAE employs state-of-the-art technology and follows stringent protocols to ensure the accuracy and reliability of the test results, providing patients and their families with critical information for managing the condition.
The FBXL4 Gene Mitochondrial DNA Depletion Syndrome Type 13 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the FBXL4 gene, which are linked to Mitochondrial DNA Depletion Syndrome Type 13 (MTDPS13). This condition is a rare genetic disorder characterized by a significant reduction in mitochondrial DNA within cells, leading to a spectrum of clinical manifestations including muscle weakness, neurological impairments, and developmental delays, among others. The test is crucial for early diagnosis and management of the syndrome, enabling healthcare providers to tailor treatment plans to the specific needs of the patient.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA sample, usually obtained through a blood draw, to detect mutations in the FBXL4 gene. The cost of the test is 4400 AED, reflecting the comprehensive analysis and the sophisticated technology employed to ensure accurate diagnosis. By identifying the genetic basis of MTDPS13, this test plays a pivotal role in guiding clinical interventions and supporting families in understanding the implications of the disorder.
The POLG Gene Mitochondrial DNA Depletion Syndrome Type 4B Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the POLG gene. This gene is crucial for the maintenance of mitochondrial DNA, and mutations can lead to mitochondrial DNA depletion syndrome type 4B (MDDS4B), a rare genetic disorder. The syndrome is characterized by a spectrum of clinical features, including neurological and muscular impairments, which can vary significantly in severity among affected individuals.
This genetic test is instrumental in confirming the diagnosis of MDDS4B, enabling healthcare professionals to provide targeted treatment and management plans for patients. By analyzing the patient's DNA, the test can identify specific mutations in the POLG gene that are responsible for the condition. Early diagnosis through genetic testing can be critical in managing symptoms and improving the quality of life for individuals with this syndrome.
The cost of the POLG Gene Mitochondrial DNA Depletion Syndrome Type 4B Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis required to detect the presence of mutations in the POLG gene accurately. Given the complexity and the specialized nature of this test, it represents a crucial step towards personalized medicine for patients suspected of having MDDS4B or related mitochondrial disorders.
MPV17 Gene Mitochondrial DNA Depletion Syndrome Type 6 (MTDPS6) is a rare genetic disorder characterized by a significant reduction in mitochondrial DNA (mtDNA) in affected tissues, leading to a spectrum of clinical manifestations including liver dysfunction, neurological deficits, and muscle weakness. This condition is caused by mutations in the MPV17 gene, which plays a crucial role in the maintenance of mitochondrial DNA.
To diagnose this condition, a genetic test targeting the MPV17 gene can be conducted. This test is crucial for confirming the diagnosis, understanding the disease's progression, and for family planning purposes. DNA Labs UAE offers this specialized genetic testing service. The test involves analyzing the patient's DNA to identify mutations in the MPV17 gene that are responsible for Mitochondrial DNA Depletion Syndrome Type 6.
The cost of the MPV17 Gene Mitochondrial DNA Depletion Syndrome Type 6 Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive test is conducted in a state-of-the-art laboratory setting by skilled geneticists and laboratory technicians. The process includes collecting a DNA sample, usually through a blood draw or cheek swab, followed by detailed analysis using advanced genetic sequencing technologies.
Upon completion of the test, a detailed report is provided to the patient or the ordering physician, outlining the findings and offering insights into the genetic makeup of the individual concerning the MPV17 gene. This information is vital for devising a personalized management plan for affected individuals and offers the possibility of genetic counseling for families.
The TWNK Gene Mitochondrial DNA Depletion Syndrome Type 7 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the TWNK gene, which are associated with Mitochondrial DNA Depletion Syndrome Type 7 (MTDPS7). MTDPS7 is a rare genetic condition characterized by a significant reduction in mitochondrial DNA within cells, leading to a spectrum of clinical manifestations including neurological and muscular impairments. The test plays a critical role in the early detection and management of the syndrome, allowing for tailored treatment strategies and genetic counseling for affected families. Priced at 4400 AED, this test is a crucial resource for individuals with a family history or clinical symptoms suggestive of MTDPS7, providing them with valuable insights into their genetic health.
The MFF Gene Mitochondrial Encephalomyopathy Genetic Test is a specialized diagnostic tool designed to identify mutations in the MFF gene, which are associated with mitochondrial encephalomyopathy. This condition is a group of disorders characterized by brain and muscle dysfunction, attributed to abnormalities in the mitochondria, the energy-producing structures within cells. Symptoms of mitochondrial encephalomyopathy can vary widely but often include muscle weakness, neurological deficits, and developmental delays.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to detect specific mutations in the MFF gene that are linked to the development of mitochondrial encephalomyopathy. The process is non-invasive, requiring only a sample of blood or saliva from the patient.
The cost of the MFF Gene Mitochondrial Encephalomyopathy Genetic Test is 4400 AED. This investment covers the comprehensive analysis necessary to achieve a conclusive result, providing crucial information for the diagnosis, management, and potential treatment plans for individuals affected by or at risk of developing mitochondrial encephalomyopathy. It's an invaluable resource for families seeking answers and medical professionals looking for confirmation of this condition, facilitating targeted therapeutic interventions and supportive care strategies tailored to the patient's specific genetic makeup.
